10-K: Annual report pursuant to Section 13 and 15(d)
Published on February 23, 2018
Exhibit 12.1
RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth our ratio of earnings to fixed charges on a reported basis for the periods indicated. Earnings consist of income from continuing operations plus fixed charges. Fixed charges consist of interest expense, amortization of deferred financing costs and costs related to retiring certain debt early. We have calculated the ratio of earnings to fixed charges by adding net income from continuing operations to fixed charges and dividing that sum by such fixed charges.
Omega Healthcare Investors, Inc.
| Year Ended December 31, | ||||||||||||||||||||
| 2013 | 2014 | 2015 | 2016 | 2017 | ||||||||||||||||
| (in thousands) | ||||||||||||||||||||
| Net income | $ | 172,521 | $ | 221,349 | $ | 233,315 | $ | 383,367 | $ | 104,910 | ||||||||||
| Interest expense (1) | 92,048 | 126,869 | 183,208 | 175,561 | 220,243 | |||||||||||||||
| Income before fixed charges | $ | 264,569 | $ | 348,218 | $ | 416,523 | $ | 558,928 | $ | 325,153 | ||||||||||
| Capitalized interest | $ | 190 | $ | — | $ | 3,701 | $ | 6,594 | $ | 7,991 | ||||||||||
| Interest expense (1) | 92,048 | 126,869 | 183,208 | 175,561 | 220,243 | |||||||||||||||
| Total fixed charges | $ | 92,238 | $ | 126,869 | $ | 186,909 | $ | 182,155 | $ | 228,234 | ||||||||||
| Earnings / fixed charge coverage ratio | 2.9 | x | 2.7 | x | 2.2 | x | 3.1 | x | 1.4 | x | ||||||||||
| (1) | Includes interest refinancing costs, gains and losses on refinancing and amortization of deferred financing costs. |
OHI Healthcare Properties Limited Partnership
| Year Ended December 31, | ||||||||||||||||||||
| 2013 | 2014 | 2015 (3) |
2016 | 2017 | ||||||||||||||||
| (in thousands) | ||||||||||||||||||||
| Net income | $ | — | $ | — | $ | 190,263 | $ | 383,367 | $ | 104,910 | ||||||||||
| Interest expense (2) | — | — | 140,119 | 175,561 | 220,243 | |||||||||||||||
| Income before fixed charges | $ | — | $ | — | $ | 330,382 | $ | 558,928 | $ | 325,153 | ||||||||||
| Capitalized interest | $ | — | $ | — | $ | 3,681 | $ | 6,594 | $ | 7,991 | ||||||||||
| Interest expense (2) | — | — | 140,119 | 175,561 | 220,243 | |||||||||||||||
| Total fixed charges | $ | — | $ | — | $ | 143,800 | $ | 182,155 | $ | 228,234 | ||||||||||
| Earnings / fixed charge coverage ratio | — | — | 2.3 | x | 3.1 | x | 1.4 | x | ||||||||||||
| (2) | Includes interest refinancing costs, gains and losses on refinancing and amortization of deferred financing costs. |
| (3) | The period is from April 1, 2015 (Aviv Merger date) through December 31, 2015. |